Republic of the Philippines

Cebu Normal University

Osmeña Blvd. Cebu City, 6000 Philippines

College of Nursing
Center of Excellence (COE) | Level IV Re-Accredited (AACCUP)
Telephone No.: (032) 254 4837
Email: cn@cnu.edu.ph/secretary@cnunursing.org
DRUG STUDY

Patient’s Initials: M. S. Date of Admission: April 25, 2021 Diagnosis: Osteoporosis

Age: 65 years old Height: 160 cm Weight: 50 kg Clinical Intervention: Osteoporosis Screening
Sex: Female Ward: Orthopedic Ward Bed No.: 8 Name of Physician: Dr. Alex Morales

Name of Mechanism of Nursing

Classification Indication Contraindication Side Effects
Drug Action Responsibilities
Generic Pharmacologic Inhibits General Indications: Contraindicated CNS: headache, Before:
Name: Class: prostaglandin Treatment of: in: dizziness, drowsiness, ● Check doctor’s order.
Ibuprofen Nonopioid synthesis. Inflammatory disorders Hypersensitivity intraventricular ● Check medication,
analgesics including rheumatoid (cross-sensitivity hemorrhage (ibuprofen medication’s expiration
Trade Name: Therapeutic arthritis (including may exist with other lysine), psychic date and dosage before
Advil Therapeutic Effects: juvenile) and NSAIDs, including disturbances. administering drug. 
Class: Decreased pain and osteoarthritis, aspirin); Active GI EENT: amblyopia, blurred ● Assess for signs and
Minimum Antipyretics, inflammation. Dysmenorrhea. bleeding or ulcer vision, tinnitus. symptoms of GI bleeding
dose: antirheumatics, Reduction of fever. disease; Chewable CV: arrhythmias, edema, (tarry stools,
10 mg nonopioid Patient’s Indication:  tablets contain hypertension. lightheadedness,
analgesics, Pharmacokinetic For the patient’s aspartame and GI: GI BLEEDING, hypotension), renal
Maximum nonsteroidal s management of pain. should not be used HEPATITIS, constipation, dysfunction (elevated
dose: anti- Absorption: in patients with dyspepsia, nausea, BUN and creatinine levels,
800 mg inflammatory Oral formulation is phenylketonuria; necrotizing enterocolitis decreased urine output),
agents well absorbed Peri-operative pain (ibuprofen lysine), and hepatic impairment
Patients’ (80%) from the GI from coronary artery vomiting, abdominal (elevated liver enzymes,
Dose Pregnancy tract; IV bypass graft (CABG) discomfort. jaundice). Geri: Higher
400 mg Category: administration surgery; OB: Avoid GU: cystitis, hematuria, risk for poor outcomes or
Category C (up results in complete after 30 wk renal failure. death from GI bleeding.
Route: to 30 wk bioavailability. gestation (may Derm: EXFOLIATIVE Age-related renal
PO gestation), D cause premature DERMATITIS, impairment increases risk
(starting at 30 Distribution: closure of fetal STEVENSJOHNSON of hepatic and renal
Frequency: wk gestation) Does not enter ductus arteriosus); SYNDROME, TOXIC toxicity.
PRN for pain, breast milk in Pedi: Ibuprofen EPIDERMAL ● Pain: Assess pain (note
q6hrs significant lysine: Preterm NECROLYSIS, rashes, type, location, and
amounts. neonates with injection site reaction. intensity) prior to and 1–2
Form: untreated infection, Hemat: anemia, blood hr following
Tablet Protein Binding: congenital heart dyscrasias, prolonged administration.
99%. disease where bleeding time.
Availability: patency of PDA is Misc: allergic reactions During:
(generic Metabolism and necessary for including ANAPHYLAXIS. ● Verify client’s identity.
available) Excretion: pulmonary or ● Inform client of the
Tablets: 100 Mostly metabolized systemic blood flow, Interactions Drug- purpose of the drug.
mgOTC, 200 by the liver; small bleeding, Drug: ● Make sure to administer
mgOTC, 300 amounts (1%) thrombocytopenia, May limit the adhering to the patient’s
mg, 400 mg, excreted coagulation defects, cardioprotective effects rights in medication
600 mg, 800 unchanged by the necrotizing of low-dose aspirin. administration such as
mg. Capsules kidneys. enterocolitis, Concurrent use with right drug, dosage,
(liqui-gels): significant renal aspirin may decrease patient, route, and time.
200 mgOTC. Half-life: dysfunction. effectiveness of ● Assess patient for skin
Chewable Neonates: 26–43 ibuprofen. Additive rash frequently during
tablets (fruit, hr; Children: 1–2 Use Cautiously in: adverse GI side effects therapy. Discontinue
grape, hr; Adults: 2–4 hr. Cardiovascular with aspirin, oral ibuprofen at first sign of
orange, and disease (may potassium, other NSAIDs, rash; may be life-
citrus flavor ): increase risk of corticosteroids, or threatening. Stevens-
50 mgOTC, cardiovascular alcohol. Chronic use with Johnson syndrome or
100 mgOTC. events); Renal or acetaminophen may toxic epidermal necrolysis
Liquid (berry hepatic disease, increase risk of adverse may develop. Treat
flavor): 100 dehydration, or renal reactions. May symptomatically; may
mg/5 mLOTC. patients on decrease effectiveness of recur once treatment is
Oral nephrotoxic drugs diuretics, ACE inhibitors, stopped.
suspension (may increase risk of or other ● Administration of higher
(fruit, berry, renal toxicity); antihypertensives. May than recommended doses
grape flavor): Aspirin triad patients increase hypoglycemic does not provide
100 mg/5 (asthma, nasal effects of insulin or oral increased pain relief but
mLOTC, 100 polyps, and aspirin hypoglycemic agents. may increase incidence of
mg/2.5 intolerance); can May increase serum side effects.
mLOTC. cause fatal lithium levels and risk of ● Patient should be well
Pediatric anaphylactoid toxicity. Increase risk of hydrated before
drops (berry reactions; Geri: toxicity from administration to prevent
flavor): 50 Increase risk of methotrexate. renal adverse reactions.
mg/1.25 adverse reactions Probenecid increase risk Do not give to neonates
mLOTC. secondary to age- of toxicity from with urine output 0.6
Solution for related decrease in ibuprofen. Increase risk mL/kg/hour.
injection: 100 renal and hepatic of bleeding with ● Use lowest effective
mg/mL function, concurrent cefotetan, cefoperazone, dose for shortest period
(Caldolor), illnesses, and corticosteroids, valproic of time, especially in the
17.1 mg/mL medications; Chronic acid, thrombolytics, elderly.
as lysine, 10 alcohol use/abuse; warfarin, and drugs ● Coadministration with
mg/mL as Coagulation affecting platelet function opioid analgesics may
ibuprofen disorders; OB: Use including clopidogrel, have additive analgesic
base cautiously up to 30 ticlopidine, abciximab, effects and may permit
(Neoprofen). wk gestation; avoid eptifibatide, or tirofiban. lower opioid doses.
In after that; Lactation: Increase risk of adverse ● PO: For rapid initial
combination Use cautiously; Pedi: hematologic reactions effect, administer 30 min
with: Safety not with antineoplastics or before or 2 hr after meals.
decongestants established for radiation therapy. May be administered with
, OTC, infants 6 mo (oral) Increase risk of food, milk, or antacids to
hydrocodone and children more nephrotoxicity with decrease GI irritation.
(Vicoprofen), than 17 yr (IV cyclosporine. Tablets may be crushed
famotidine Caldolor); Ibuprofen and mixed with fluids or
(Duexis). lysine: Drug-Natural food; 800-mg tablet can
Hyperbilirubinemia Products: be dissolved in water.
in neonates (may Increase bleeding risk
displace bilirubin with, arnica, chamomile, After:
from albumin feverfew, garlic, ginger, ● Instruct patient to take
binding sites). ginkgo, Panax ginseng, medication as directed.
and others. ● Advise patients to take
Exercise Extreme ibuprofen with a full glass
Caution in: of water and to remain in
History of GI an upright position for
bleeding or GI ulcer 15– 30 min after
disease. administration.
● Instruct patient to take
medication as directed.
Take missed doses as
soon as remembered but
not if almost time for next
dose. Do not double
doses. Pedi: Teach
parents and caregivers to
calculate and measure
doses accurately and to
use measuring device
supplied with product.
● May cause drowsiness
or dizziness. Advise
patient to avoid driving or
other activities requiring
alertness until response to
medication is known.
● Caution patient to avoid
the concurrent use of
alcohol, aspirin,
acetaminophen, and other
OTC or herbal products
without consulting health
care professional.
● Advise patient to inform
health care professional of
medication regimen prior
to treatment or surgery.
● Instruct patients not to
take OTC ibuprofen
preparations for more
than 10 days for pain or
more than 3 days for
fever, and to consult
health care professional if
symptoms persist or
 worsen. Many OTC
products contain
ibuprofen; avoid
duplication.
● Caution patient that use
of ibuprofen with 3 or
more glasses of alcohol
per day may increase the
risk of GI bleeding.
● Advise patient to
consult health care
professional if rash,
itching, visual
disturbances, tinnitus,
weight gain, edema,
epigastric pain, dyspepsia,
black stools,
hematemesis, persistent
headache, or influenza-
like syndrome (chills,
fever, muscle aches, pain)
occurs
• Document the medicine
administered.  
References: References: References: References: References: References: References:
Vallerand, Vallerand, A.H., Vallerand, A.H., Vallerand, A.H., Sanoski, Vallerand, A.H., Vallerand, A.H., Sanoski, Vallerand, A.H., Sanoski,
A.H., Sanoski, Sanoski, C.A., & Sanoski, C.A., & C.A., & Deglin, J.H. Sanoski, C.A., & C.A., & Deglin, J.H. C.A., & Deglin, J.H.
C.A., & Deglin, J.H. Deglin, J.H. (2017). (2017). Davis’s Drug Deglin, J.H. (2017). (2017). Davis’s Drug (2017). Davis’s Drug
Deglin, J.H. (2017). Davis’s Davis’s Drug Guide Guide for Nurses, 15th Davis’s Drug Guide Guide for Nurses, 15th Guide for Nurses, 15th ed.
(2017). Drug Guide for for Nurses, 15th ed. Philadelphia: F.A. for Nurses, 15th ed. ed. Philadelphia: F.A. Philadelphia: F.A. Davis
Davis’s Drug Nurses, 15th ed. ed. Philadelphia: Davis Company. Philadelphia: F.A. Davis Company. Company.
Guide for Philadelphia: F.A. Davis Davis Company.
Nurses, 15th F.A. Davis Company. MIMS. (n. d.). MIMS. (n. d.). Ibuprofen. MIMS. (n. d.). Ibuprofen.
ed. Company. Ibuprofen. Retrieved MIMS. (n. d.). Retrieved from Retrieved from
Philadelphia: MIMS. (n. d.). from Ibuprofen. Retrieved https://www.mims.com/p https://www.mims.com/p
F.A. Davis MIMS. (n. d.). Ibuprofen. https://www.mims.com/ from hilippines/drug/info/ibupr hilippines/drug/info/ibupr
Company. Ibuprofen. Retrieved from philippines/drug/info/ibu https://www.mims.c ofen?mtype=generic. ofen?mtype=generic.
Retrieved from https://www.mims. profen?mtype=generic. om/philippines/drug/
MIMS. (n. d.). https://www.mi com/philippines/dr info/ibuprofen?
Ibuprofen. ms.com/philippin ug/info/ibuprofen? mtype=generic.
Retrieved es/drug/info/ibu mtype=generic.
from profen?
https://www. mtype=generic.
mims.com/phil
ippines/drug/i
nfo/ibuprofen
?
mtype=generi
c.
 PRODUCT ASSESSMENT RUBRICS FOR DRUG
STUDY
Student Name: Rose Leen T. Year/Section: BSN-3B Date: April 26, 2021 Score: /30
Rosell
Directions: Please select the appropriate rating using the following descriptions.

Elemen Very Satisf Needs Comme

t Satisfacto actory Improveme nts
ry nt
Drug ☐ Accurately presented all of the patient ☐ Accurately presented most of the ☐ Accurately presented some of the patient
Infor and drug information (name [brand & patient and drug information related to and drug information related to the case. 2
matio generic], dosage [patient’s dose; min. & the case. 1 missing information or error or more missing information or errors
n max], frequency, route, availability, noted. [2] noted. [1]
(10% contents) related to the case. [3]
)
Classifi ☐ Accurately presented the classification ☐ Accurately presented the classification ☐ Inaccurately presented the classification
catio (therapeutic and pharmacologic) related to related to the drug but with 1 irrelevant related to the drug. Classification is not
n the drug. [3] information or error noted. [2] relevant to the drug. [1]
(10
%)
☐ Accurately presented the indication/s ☐ Accurately presented the indication/s ☐ Inaccurately presented the indication/s
Indication
(general & patient- specific) related to the related to the drug but with 1 irrelevant related to the drug. Indication is not
(10%)
drug. [3] information or error noted. [2] relevant to the drug. [1]
Mechan ☐ Accurately presented the ☐ Accurately presented the mechanism ☐ Inaccurately presented the mechanism of
ism of mechanism of action of action of the drug but with 1 irrelevant action of the drug. Mechanism of action is
Action
(pharmacokinetics, pharmacodynamics) of information or error noted. [2] not relevant to the drug. [1]
(10%)
the drug. [3]
☐ Accurately presented all of the common ☐ Accurately presented most of the ☐ Accurately presented some of the
Contraind
contraindications related to the drug. [3] common contraindications related to the common contraindications related to the
icatio
drug. 1 missing information or error drug. 2 or more missing information or
n
noted. [2] errors noted. [1]
(10%
)
Side ☐ Accurately presented all of the common ☐ Accurately presented most of the ☐ Accurately presented some of the
Effe side effects related to the drug. [3] common side effects related to the drug. common side effects related to the drug. 3
cts 1-2 missing information or errors noted. or more missing information or errors
(10
%) [2] noted. [1]
Nursing ☐ Accurately presented all of the ☐ Accurately presented most of the ☐ Accurately presented some of the
Respons common nursing responsibilities (before, common nursing common nursing
ibilities during, and after) related to the drug. [9] responsibilities related to the drug. 1-2 responsibilities related to the drug. 3 or
(30%)
missing information or errors noted. [7] more missing information or errors noted.
 [3]
Refer ☐ Presented at least 2 sources that are ☐ Presented only one source that is ☐ No source was presented. Sources are not

enc updated (within 5 years), relevant, and updated (within 5 years), relevant, and updated (more than 5 years), relevant, and
es credible. [3] credible. Other sources are not updated, credible. [1]
(10 credible or relevant. [2]
%)
Sub-score = = =

Evaluated by:

Signature over Printed Name of Clinical Instructor